OnDemand Wills Eye Hospital Ophthalmology Review Course 2025

Registration for the course is $350 per attendee. Includes access to course materials digitally through Dropbox.

All video content will be available to view from March 1st, 2025 through February 28th, 2026.

Course Director

Ralph C. Eagle, Jr., MD

This online course is a comprehensive and intensive review of ophthalmology for practicing ophthalmologists and ophthalmology residents and fellows. Topics taught by our world-renowned faculty range from anatomy, corneal diseases, eyelid, glaucoma, imaging, immunology, neuro-ophthalmology, oncology, orbit, ocular pathology, pediatrics, pharmacology, physiology, optics and refraction, and retina.

Guest Faculty
David L. Guyton, MD, Professor of Ophthalmology,
The Wilmer Ophthalmological Institute, Johns Hopkins University,
Baltimore, MD

Kristina Irsch, PhD, Assistant Professor of Ophthalmology,
The Wilmer Ophthalmological Institute, Johns Hopkins University,
Baltimore, MD

Rod Foroozan, MD, Professor of Neuro-ophthalmology,
Baylor College of Medicine,
Houston, TX

Hermann D. Schubert, MD, Professor of Clinical Ophthalmology and Pathology,
Columbia University,
New York, NY

Wills Eye Hospital Faculty 
Jurij R. Bilyk, MD, Attending Surgeon, Oculoplastic Service

Jacqueline Carrasco, MD, Attending Surgeon, Oculoplastic & Orbital Surgery

Jordan D. Deaner, MD, Attending Surgeon, Retina Service

Ralph C. Eagle, Jr., MD, Service Chief, Department of Pathology

Mitchell S. Fineman, MD, Attending Surgeon, Retina Service

Nicholas Hadjokas, MD, Attending Surgeon, Cornea and Cataract Surgery

Lauren Hock, MD, Attending Surgeon, Glaucoma Service

Aditya Kanesa-thasan, MD, Attending Surgeon, Cornea and Cataract Surgery

Michael A. Klufas, MD, Attending Surgeon, Retina Service

Daniel Lee, MD, Attending Surgeon, Glaucoma Service

Jonathan S. Myers, MD, Service Chief, Glaucoma Service

Bruce M. Schnall, MD, Attending Surgeon, Adult and Pediatric Strabismus

Carol L. Shields, MD, Service Chief, Oncology Service

Zeba A. Syed, MD, Attending Surgeon, Cornea Service

Barry N. Wasserman, MD, Attending Surgeon, Pediatric Ophthalmology Service

This activity has been approved for AMA PRA Category 1 Credit™

1. Provide a comprehensive review of topics in ophthalmology including: Optics and Refraction; Antomy and Embryology; Retina and Vitreous; Ocular Pathology; Orbit, Eyelid and Lacrimal System; Pharmacology and Therapeutics; Ocular Tumors; Neuro-Ophthalmology; Corneal and External Diseases; Uveitis and AIDS; Glaucoma; Pediatric Ophthalmology and Strabismus; CT and MRI Imaging of Eye and Orbit.
2. Better understand the pathophysiology of most ophthalmic disease.
3. Perform appropriate diagnostic tests and differential diagnosis for most ophthalmic diseases.

AMA PRA Statement
Wills Eye Hospital designates this Enduring Material for a maximum of 58.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Jurij R. Bilyk, MD
Wills Eye Hospital

Faculty

Nothing to disclose

Jackie R. Carrasco, MD
Wills

Faculty

Speakers Bureau-Amgen

Jordan Deaner, MD
Mid Atlantic Retina, Wills Eye Hospital

Faculty

Consulting Fee-EyePoint Pharmaceuticals (Relationship has ended)|Consulting Fee-Alimera Sciences (Relationship has ended)|Consulting Fee-Genentech (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Consulting Fee-Regeneron (Relationship has ended)

Mitchell Fineman, MD
Wills Eye Hospital

Faculty

Nothing to disclose

Rod Foroozan, MD
Baylor College of Medicine

Faculty

Nothing to disclose

David L. Guyton, MD
Wilmer Eye Institute, Johns Hopkins University School of Medicine

Faculty

Grant or research support-Rebion, Inc. (Relationship has ended)

Nicholas Hadjokas, MD
Wills Eye Hospital

Faculty

Independent Contractor (included contracted research)-RxSight|Consulting Fee-Glaukos Corporation

Lauren Hock, MD
Wills Eye Hospital

Faculty

Grant or research support-National Eye Institute

Kristina Irsch, PhD
Vision Insitute - CNRS & Wilmer Eye Insitute - Johns Hopkins University

Faculty

Nothing to disclose

Aditya Kanesa-thasan, MD
Wills Eye Hospital

Faculty

Nothing to disclose

Michael Klufas, MD
Mid Atlantic Retina/Wills Eye

Faculty

Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Genentech|Consulting Fee-Regeneron|Honoraria-Coherus (Relationship has ended)|Honoraria-Biogen (Relationship has ended)|Consulting Fee-Abbvie|Grant or research support-Bausch + Lomb|Consulting Fee-Dutch Ophthalmic USA|Consulting Fee-Alimera Sciences

Daniel Lee, MD
Wills Eye Hospital

Faculty

Grant or research support-Allergan (Relationship has ended)|Grant or research support-Equinox (Relationship has ended)|Grant or research support-Glaukos Corporation (Relationship has ended)|Grant or research support-Mati (Relationship has ended)|Grant or research support-New World Medical (Relationship has ended)|Grant or research support-Nicox (Relationship has ended)|Grant or research support-Olleyes (Relationship has ended)|Consulting Fee-Quidel (Relationship has ended)|Grant or research support-Santen Pharmaceuticals (Relationship has ended)|Grant or research support-Ocular Therapeutix (Relationship has ended)

Jonathan S. Myers, MD
Wills Eye Hospital

Faculty

Stocks or stock options, excluding diversified mutual funds-Avisi|Stocks or stock options, excluding diversified mutual funds-Olleyes|Grant or research support-Allergan (Relationship has ended)|Grant or research support-Glaukos Corporation|Grant or research support-Nicox (Relationship has ended)|Grant or research support-Santen Pharmaceuticals (Relationship has ended)|Grant or research support-Guardian (Relationship has ended)|Grant or research support-Laboratories Thea Inc|Grant or research support-Ocular Therapeutix (Relationship has ended)|Grant or research support-Elios|Grant or research support-PLU Ophthalmic

Bruce M. Schnall, MD
Wills Eye Hospital

Faculty

Nothing to disclose

Hermann D. Schubert, MD
Edward S. Harkness Eye Institute, Columbia University

Faculty

Nothing to disclose

Carol L. Shields, MD
Shields and Shields MD PC

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aura Biosciences|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Immunocore, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Ideaya Biosciences, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-iOnctura, Inc.

Barry N. Wasserman, MD
BARRY N WASSERMAN MD LLC

Faculty

Nothing to disclose

Ralph C. Eagle Jr., MD
Director
Wills Eye Hospital

Faculty, Planner

Nothing to disclose